anti-Defb3 antibody product blog
Tags: Antibody; DEFB3; Polyclonal Antibody; anti-Defb3 antibody; BD3;
The Defb3 defb3 (Catalog #MBS620603) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The BD3 (beta-Defensin 3) (Biotin) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s BD3 can be used in a range of immunoassay formats including, but not limited to, ELISA (EL/EIA), Western Blot (WB).Suitable for use in ELISA and Western Blot.
Dilution: ELISA (Direct, Sandwich): 0.25-1.0ug/ml Detects 0.2ng/well of recombinant hBD-3 using 100ul/well antibody solution in conjunction with B0902-03D as a capture antibody. Allows the detection of 0.2-0.4ng/well of recombinant hBD-3.
Western Blot: 0.1-0.2ug/ml (under either reducing or non-reducing conditions) Detection limit for recombinant hBD-3 is 1.5-3.0ng/lane. Researchers should empirically determine the suitability of the Defb3 defb3 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The Defb3 defb3 product has the following accession number(s) (GI #7304997) (NCBI Accession #NP_038784.1) (Uniprot Accession #Q9WTL0). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Immunogen: Highly pure (> 98%) recombinant human Beta Defensin-3. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Defb3 are readily searchable from our website. Different antibodies against the same target such as Defb3 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. Musculoskeletal Diseases, Skin Abnormalities are some of the diseases may be linked to BD3 (beta-Defensin 3) (Biotin).